+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Automatic Parallel Peptide Synthesiser Market - Global Forecast 2025-2030- Product Image
Automatic Parallel Peptide Synthesiser Market - Global Forecast 2025-2030- Product Image
Sale

Automatic Parallel Peptide Synthesiser Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6080490
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Discover the Critical Role and Developmental Journey That Has Shaped Contemporary Automatic Parallel Peptide Synthesiser Innovations and Market Evolution

Automatic parallel peptide synthesis has emerged as a cornerstone of modern biochemical research, enabling scientists to accelerate peptide library generation and streamline drug discovery processes. As high-throughput demands intensify, these advanced synthesiser platforms deliver the precision and efficiency required to support complex experimental workflows. In this introduction, we trace the evolution of these systems, highlighting their transition from manual batch processes to fully automated solutions that enhance reproducibility and throughput.

The purpose of this executive summary is to provide decision-makers with an authoritative overview of current market dynamics, technological advancements, and strategic considerations that define the landscape of parallel peptide synthesis. By synthesizing key developments-from methodological breakthroughs to supply chain influences-this section sets the stage for a comprehensive analysis that will guide stakeholders in navigating emerging opportunities. Ultimately, this summary distills critical insights to inform planning, investment, and innovation strategies within this rapidly advancing domain.

Explore How Revolutionary Technological Advances and Evolving Research Demands Are Driving a Fundamental Transformation in Peptide Synthesiser Capabilities

Recent years have witnessed transformative shifts in peptide synthesis, driven by a convergence of technological breakthroughs and evolving research imperatives. High-fidelity reagent delivery systems now ensure exceptional coupling efficiency, while integrated real-time monitoring capabilities offer unprecedented process control. As a result, researchers can iterate experimental designs faster and with greater confidence in purity outcomes.

Moreover, the integration of microfluidic platforms has enabled miniaturization and parallelization at scales previously unattainable, reducing reagent consumption and waste. Concurrently, advances in software-driven automation facilitate seamless protocol customization, empowering users to optimize complex sequences through intuitive interfaces. Consequently, these shifts not only enhance operational productivity but also broaden accessibility, allowing academia and industry to explore novel peptide-based therapeutics and diagnostics with reduced time to insight. Ultimately, this section unpacks how these concurrent innovations are reshaping expectations for speed, scalability, and sustainability across peptide synthesis workflows.

Examine the Broad Industry Implications of Newly Introduced United States Tariff Measures and Their Strategic Influence on Peptide Synthesiser Supply Chains

In 2025, the introduction of targeted United States tariffs on critical reagents and consumables has created ripple effects throughout global peptide synthesis supply chains. These measures have elevated costs for certain amino acid derivatives and solid support resins, prompting manufacturers and end users to reassess procurement strategies. While some suppliers have mitigated the impact through localized production, others are exploring alternative sourcing regions to maintain competitive pricing structures.

Transitioning to new vendor partnerships requires thorough validation of reagent quality, and this process has inadvertently lengthened lead times for certain custom sequences. Nonetheless, proactive coordination within supply chain networks and strategic stockpiling of essential materials have emerged as viable countermeasures. As a result, stakeholders must balance the short-term challenges of tariff-induced cost increases against the long-term benefits of supply diversification and enhanced domestic production capabilities. This section elucidates how these economic policies are influencing operational resilience and strategic decision-making in peptide synthesiser markets.

Unveil the Comprehensive Segmentation Landscape Revealing How Technology Platforms and Diverse User Needs Are Defining Growth Trajectories in Peptide Synthesis

The peptide synthesiser landscape can be distilled through multiple perspectives, each revealing distinct drivers of innovation and market uptake. By technology, platforms span liquid phase methods and solid phase approaches, with the former encompassing membrane assisted processes that streamline separation and solution phase techniques that optimize reaction kinetics, while the latter includes Boc chemistry renowned for its robust side chain protection strategies alongside Fmoc chemistry favored for its orthogonality and compatibility with high-throughput automation.

In parallel, the diversity of end users informs application-specific demands. Academic and research institutes prioritize flexibility for exploratory studies, while biotechnology companies seek scalable platforms to accelerate lead identification. Contract research organizations demand reliability and throughput to fulfill external partnerships, and pharmaceutical enterprises emphasize regulatory alignment and documentation for clinical pipeline integration. Meanwhile, applications range from diagnostics, where rapid assay development is paramount, to research and development efforts that expand fundamental understanding, therapeutics that target complex disease mechanisms, and vaccine development initiatives requiring precise epitope mapping.

Lastly, synthesis scale considerations underscore throughput strategies: high throughput workflows support combinatorial screening campaigns; medium throughput systems balance customization and productivity for targeted studies; and low throughput operations serve specialized projects demanding meticulous quality control. This multifaceted segmentation framework highlights pathways for tailored product development and differentiated service offerings.

Assess the Distinct Regional Dynamics Across the Americas Europe Middle East & Africa and Asia-Pacific That Are Shaping Market Expansion in Peptide Synthesiser Adoption

Regional dynamics in peptide synthesiser adoption exhibit distinct characteristics shaped by local research ecosystems and regulatory environments. In the Americas, expansive biotechnology hubs and government-supported innovation initiatives drive demand for high-throughput automated platforms. Collaborative networks between academic centers and biopharmaceutical firms foster continuous enhancement of synthesis protocols, reinforcing competitiveness.

Across Europe the Middle East and Africa, regulatory harmonization and public-private partnerships have accelerated the integration of peptide synthesis in drug discovery pipelines. Investment in translational research infrastructure elevates adoption of membrane assisted and solution phase methods, while established contract research organizations underwrite extensive validation processes for emerging chemistries.

In the Asia-Pacific region, burgeoning pharmaceutical manufacturing capabilities and rising R&D expenditures catalyze growth in both solid phase and liquid phase synthesiser markets. Local manufacturers are rapidly scaling production to meet regional needs, while research institutes leverage medium and high throughput systems to drive vaccine development and therapeutic peptide discovery. By understanding these region-specific trends, stakeholders can align strategies with localized demands and regulatory frameworks to optimize market penetration and long-term expansion.

Identify Leading Innovation Drivers and Competitive Strategies Employed by Prominent Companies Advancing the Automatic Parallel Peptide Synthesiser Market Ecosystem

Leading companies in the automatic parallel peptide synthesiser sector demonstrate a blend of technological prowess and strategic agility. Through focused investments in proprietary reagent development, instrument miniaturization, and modular automation architectures, these organizations deliver platforms tailored to both exploratory research and high-demand production environments. Strategic alliances with chemical suppliers and software innovators further enhance their value proposition, enabling seamless integration of end-to-end synthesis workflows.

In addition, selective geographic expansions-often via partnerships with regional distributors or joint ventures-have bolstered global reach while preserving local support networks. Some firms differentiate through specialized service offerings, such as custom sequence libraries, contract synthesis services, and ongoing protocol optimization support, thereby capturing adjacent revenue streams beyond instrument sales. By continuously refining user interfaces and analytics capabilities, these companies reinforce customer loyalty, reduce adoption barriers, and position themselves at the forefront of peptide synthesis innovation.

Empower Industry Leaders with Pragmatic Strategies to Navigate Market Disruptions Harness Emerging Technologies and Capitalize on Peptide Synthesis Opportunities

Industry leaders can strengthen their market position by prioritizing interoperability across platforms and investing in open architecture designs that accommodate evolving chemistries. By forging strategic partnerships with reagent manufacturers and software developers, they can coalesce complementary expertise to deliver holistic solutions. Such collaboration not only accelerates time to market but also fosters standardized protocols, reducing validation overhead for end users.

Furthermore, enterprises should consider targeted expansions in emerging research hubs by establishing local training programs and application laboratories. These initiatives cultivate skilled users and generate valuable feedback loops for continuous product enhancement. Concurrently, incorporating sustainability metrics into design and manufacturing processes will resonate with environmentally conscious stakeholders, enhancing brand reputation. By adopting a proactive approach to regulatory alignment-anticipating shifts in compliance requirements and participating in policy forums-organizations can mitigate obstacles and secure first-mover advantages in new markets. Collectively, these recommendations equip decision-makers with a roadmap to navigate competitive pressures and capitalize on growth inflection points.

Demystify the Rigorous Research Methodology Underpinning the Market Analysis Including Data Collection Analytical Techniques and Validation Protocols

This market analysis integrates a multi-tiered research methodology, beginning with an exhaustive review of patent filings industry publications and peer-reviewed journals to capture technology trends and intellectual property landscapes. Subsequently, primary interviews with key opinion leaders across academia biotechnology companies and pharmaceutical firms provided qualitative insights into user requirements and adoption barriers. To ensure robust data triangulation, these findings were cross-referenced with procurement records regulatory filings and corporate financial disclosures.

Quantitative modeling techniques were then applied to internal datasets and third-party supply chain information, enabling a granular understanding of cost dynamics and regional distribution patterns. All analytical procedures adhered to rigorous validation protocols, including sensitivity analyses and scenario testing, to verify the reliability of conclusions under varying market conditions. Throughout this process, strict quality controls and peer reviews ensured the integrity of the final deliverables.

Synthesize the Essential Findings and Forward-Looking Insights Underscoring the Evolutionary Trajectory and Strategic Imperatives for Peptide Synthesiser Market Success

In conclusion, automatic parallel peptide synthesis stands at the nexus of innovation and application, driven by continuous advances in automation, materials science, and data analytics. The evolving tariff landscape underscores the strategic importance of resilient supply chains and local manufacturing capabilities, while segmentation analysis highlights opportunities for technology providers to tailor offerings to diverse user needs and operational scales. Regional insights emphasize the necessity of adaptive strategies attuned to regulatory environments and research priorities across the Americas Europe Middle East & Africa and Asia-Pacific.

Looking ahead, sustained investment in collaborative ecosystems and open standards will define market leaders, as will proactive engagement with emerging regions and application domains. By integrating the actionable recommendations presented herein decision-makers can position their organizations for long-term success in a dynamic and competitive field. This executive summary thus offers a comprehensive framework for navigating the complexities of peptide synthesiser markets and unlocking future growth potential.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Technology
    • Liquid Phase
      • Membrane Assisted
      • Solution Phase
    • Solid Phase
      • Boc Chemistry
      • Fmoc Chemistry
  • End Users
    • Academic And Research Institutes
    • Biotechnology Companies
    • Contract Research Organizations
    • Pharmaceutical Companies
  • Applications
    • Diagnostics
    • Research And Development
    • Therapeutics
    • Vaccine Development
  • Synthesis Scale
    • High Throughput
    • Low Throughput
    • Medium Throughput
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • CEM Corporation
  • Biotage AB
  • Shimadzu Corporation
  • Tecan Group Ltd.
  • Intavis Bioanalytical Instruments AG
  • CSBio, Inc.
  • SPT Labtech Ltd.
  • Protein Technologies LLC

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of microfluidic platforms with AI-driven protocols to accelerate peptide library generation
5.2. Implementation of green chemistry reagents and solvent recycling systems in high-throughput synthesizers
5.3. Deployment of multi-modal purification modules inline with synthesis to reduce cycle times and labor
5.4. Development of customizable peptide modification modules enabling on-demand functional peptide screening
5.5. Emergence of remote monitoring and cloud-based control software ensuring real-time process analytics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Automatic Parallel Peptide Synthesiser Market, by Technology
8.1. Introduction
8.2. Liquid Phase
8.2.1. Membrane Assisted
8.2.2. Solution Phase
8.3. Solid Phase
8.3.1. Boc Chemistry
8.3.2. Fmoc Chemistry
9. Automatic Parallel Peptide Synthesiser Market, by End Users
9.1. Introduction
9.2. Academic And Research Institutes
9.3. Biotechnology Companies
9.4. Contract Research Organizations
9.5. Pharmaceutical Companies
10. Automatic Parallel Peptide Synthesiser Market, by Applications
10.1. Introduction
10.2. Diagnostics
10.3. Research And Development
10.4. Therapeutics
10.5. Vaccine Development
11. Automatic Parallel Peptide Synthesiser Market, by Synthesis Scale
11.1. Introduction
11.2. High Throughput
11.3. Low Throughput
11.4. Medium Throughput
12. Americas Automatic Parallel Peptide Synthesiser Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Automatic Parallel Peptide Synthesiser Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Automatic Parallel Peptide Synthesiser Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Merck KGaA
15.3.2. Thermo Fisher Scientific Inc.
15.3.3. CEM Corporation
15.3.4. Biotage AB
15.3.5. Shimadzu Corporation
15.3.6. Tecan Group Ltd.
15.3.7. Intavis Bioanalytical Instruments AG
15.3.8. CSBio, Inc.
15.3.9. SPT Labtech Ltd.
15.3.10. Protein Technologies LLC
16. Research AI17. Research Statistics18. Research Contacts19. Research Articles20. Appendix
List of Figures
FIGURE 1. AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET: RESEARCHAI
FIGURE 24. AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET: RESEARCHSTATISTICS
FIGURE 25. AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET: RESEARCHCONTACTS
FIGURE 26. AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY MEMBRANE ASSISTED, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY MEMBRANE ASSISTED, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLUTION PHASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLUTION PHASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY BOC CHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY BOC CHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY FMOC CHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY FMOC CHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY HIGH THROUGHPUT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY HIGH THROUGHPUT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LOW THROUGHPUT, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LOW THROUGHPUT, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY MEDIUM THROUGHPUT, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY MEDIUM THROUGHPUT, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 83. CANADA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 84. CANADA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 85. CANADA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2018-2024 (USD MILLION)
TABLE 86. CANADA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2025-2030 (USD MILLION)
TABLE 87. CANADA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2018-2024 (USD MILLION)
TABLE 88. CANADA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2025-2030 (USD MILLION)
TABLE 89. CANADA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 90. CANADA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 91. CANADA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 92. CANADA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 93. CANADA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2024 (USD MILLION)
TABLE 94. CANADA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2025-2030 (USD MILLION)
TABLE 95. MEXICO AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 96. MEXICO AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 97. MEXICO AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2018-2024 (USD MILLION)
TABLE 98. MEXICO AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2025-2030 (USD MILLION)
TABLE 99. MEXICO AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2018-2024 (USD MILLION)
TABLE 100. MEXICO AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2025-2030 (USD MILLION)
TABLE 101. MEXICO AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 102. MEXICO AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 103. MEXICO AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 104. MEXICO AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 105. MEXICO AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2024 (USD MILLION)
TABLE 106. MEXICO AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2025-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 146. UNITED KINGDOM AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2025-2030 (USD MILLION)
TABLE 157. GERMANY AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 158. GERMANY AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 159. GERMANY AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2018-2024 (USD MILLION)
TABLE 160. GERMANY AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2025-2030 (USD MILLION)
TABLE 161. GERMANY AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2018-2024 (USD MILLION)
TABLE 162. GERMANY AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2025-2030 (USD MILLION)
TABLE 163. GERMANY AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 164. GERMANY AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 165. GERMANY AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 166. GERMANY AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 167. GERMANY AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2024 (USD MILLION)
TABLE 168. GERMANY AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2025-2030 (USD MILLION)
TABLE 169. FRANCE AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 170. FRANCE AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 171. FRANCE AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2018-2024 (USD MILLION)
TABLE 172. FRANCE AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2025-2030 (USD MILLION)
TABLE 173. FRANCE AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2018-2024 (USD MILLION)
TABLE 174. FRANCE AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2025-2030 (USD MILLION)
TABLE 175. FRANCE AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 176. FRANCE AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 177. FRANCE AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 178. FRANCE AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 179. FRANCE AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2024 (USD MILLION)
TABLE 180. FRANCE AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2025-2030 (USD MILLION)
TABLE 181. RUSSIA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 182. RUSSIA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 191. RUSSIA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2024 (USD MILLION)
TABLE 192. RUSSIA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2025-2030 (USD MILLION)
TABLE 193. ITALY AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 194. ITALY AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 195. ITALY AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2018-2024 (USD MILLION)
TABLE 196. ITALY AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2025-2030 (USD MILLION)
TABLE 197. ITALY AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2018-2024 (USD MILLION)
TABLE 198. ITALY AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2025-2030 (USD MILLION)
TABLE 199. ITALY AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 200. ITALY AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 201. ITALY AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 202. ITALY AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 203. ITALY AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2024 (USD MILLION)
TABLE 204. ITALY AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2025-2030 (USD MILLION)
TABLE 205. SPAIN AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 206. SPAIN AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 207. SPAIN AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2018-2024 (USD MILLION)
TABLE 208. SPAIN AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2025-2030 (USD MILLION)
TABLE 209. SPAIN AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2018-2024 (USD MILLION)
TABLE 210. SPAIN AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2025-2030 (USD MILLION)
TABLE 211. SPAIN AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 212. SPAIN AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 213. SPAIN AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 214. SPAIN AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 215. SPAIN AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2024 (USD MILLION)
TABLE 216. SPAIN AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2025-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2025-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 230. SAUDI ARABIA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2024 (USD MILLION)
TABLE 240. SAUDI ARABIA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2025-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 242. SOUTH AFRICA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2018-2024 (USD MILLION)
TABLE 244. SOUTH AFRICA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2024 (USD MILLION)
TABLE 252. SOUTH AFRICA AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2025-2030 (USD MILLION)
TABLE 253. DENMARK AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 254. DENMARK AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 255. DENMARK AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2018-2024 (USD MILLION)
TABLE 256. DENMARK AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2025-2030 (USD MILLION)
TABLE 257. DENMARK AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2018-2024 (USD MILLION)
TABLE 258. DENMARK AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2025-2030 (USD MILLION)
TABLE 259. DENMARK AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 260. DENMARK AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 261. DENMARK AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 262. DENMARK AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 263. DENMARK AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2024 (USD MILLION)
TABLE 264. DENMARK AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2025-2030 (USD MILLION)
TABLE 265. NETHERLANDS AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 266. NETHERLANDS AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 267. NETHERLANDS AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2018-2024 (USD MILLION)
TABLE 268. NETHERLANDS AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2025-2030 (USD MILLION)
TABLE 269. NETHERLANDS AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2018-2024 (USD MILLION)
TABLE 270. NETHERLANDS AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 273. NETHERLANDS AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 274. NETHERLANDS AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 275. NETHERLANDS AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2024 (USD MILLION)
TABLE 276. NETHERLANDS AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SYNTHESIS SCALE, 2025-2030 (USD MILLION)
TABLE 277. QATAR AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 278. QATAR AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 279. QATAR AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2018-2024 (USD MILLION)
TABLE 280. QATAR AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY LIQUID PHASE, 2025-2030 (USD MILLION)
TABLE 281. QATAR AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2018-2024 (USD MILLION)
TABLE 282. QATAR AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY SOLID PHASE, 2025-2030 (USD MILLION)
TABLE 283. QATAR AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 284. QATAR AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 285. QATAR AUTOMATIC PARALLEL PEPTIDE SYNTHESISER MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 286. QATAR AUTOMATIC PARALLEL P

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Automatic Parallel Peptide Synthesiser market report include:
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • CEM Corporation
  • Biotage AB
  • Shimadzu Corporation
  • Tecan Group Ltd.
  • Intavis Bioanalytical Instruments AG
  • CSBio, Inc.
  • SPT Labtech Ltd.
  • Protein Technologies LLC

Related Topics

Related Reports

High-throughput Peptide Synthesizer Market - Global Forecast 2025-2030 - Product Image

High-throughput Peptide Synthesizer Market - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Automated Parallel Peptide Synthesizer Market - Global Forecast 2025-2030 - Product Image

Automated Parallel Peptide Synthesizer Market - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Peptide Synthesis Market Size, Share & Trends Analysis Report By Product (Equipment, Reagents & Consumables), By Application (Therapeutics, Diagnosis), By Technology (Solid Phase Peptide Synthesis), By End-use, By Region, And Segment Forecasts, 2025 - 2033 - Product Image

Peptide Synthesis Market Size, Share & Trends Analysis Report By Product (Equipment, Reagents & Consumables), By Application (Therapeutics, Diagnosis), By Technology (Solid Phase Peptide Synthesis), By End-use, By Region, And Segment Forecasts, 2025 - 2033

  • Report
  • 150 Pages
  • Global
From
Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Instruments (Peptide Synthesizer, Chromatography, Lyophilizer), Technique (Solid-Phase, Solution-Phase, Hybrid), Services, Application (Therapeutics), End User - Global Forecast to 2029 - Product Image

Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Instruments (Peptide Synthesizer, Chromatography, Lyophilizer), Technique (Solid-Phase, Solution-Phase, Hybrid), Services, Application (Therapeutics), End User - Global Forecast to 2029

  • Report
  • 564 Pages
  • Global
From
Peptide Synthesis Market Industry Trends and Global Forecasts to 2035, by Type of Peptide Synthesis Method, Type of Chemical Synthesis, Contract Manufacturing Organization Size and Key Geographical Regions - Product Image

Peptide Synthesis Market Industry Trends and Global Forecasts to 2035, by Type of Peptide Synthesis Method, Type of Chemical Synthesis, Contract Manufacturing Organization Size and Key Geographical Regions

  • Report
  • 390 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.